表紙
市場調査レポート

癌診断検査市場:新興の検査、新しい技術を開発中の企業

2015 Emerging Cancer Diagnostic Tests and Companies Developing New Technologies

発行 Venture Planning Group 商品コード 322464
出版日 ページ情報 英文 260 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。

Local License: 同一事業所内

Back to Top
癌診断検査市場:新興の検査、新しい技術を開発中の企業 2015 Emerging Cancer Diagnostic Tests and Companies Developing New Technologies
出版日: ページ情報: 英文 260 Pages
概要

当レポートでは、世界の癌診断検査市場について調査分析し、現在/新興の癌診断検査に対する臨床的意義と市場ニーズの概要のほか、新しい技術・製品・応用を開発/マーケティング中の主要企業・大学・研究センターなどについて、体系的な情報を提供しています。

目次

  • 1. イントロダクション
  • 2. 腫瘍マーカーの分類
  • 3. ACTH
  • 4. アルファフェトプロテイン(AFP)
  • 5. β2ミクログロブリン
  • 6. CA 15-3/27.29
  • 7. CA 19-9
  • 8. CA-125
  • 9. カルシトニン
  • 10. 癌胎児性抗原(CEA)
  • 11. エストロゲン・プロゲステロン受容体
  • 12. フェリチン
  • 13. ガストリン
  • 14. ヒト絨毛性ゴナドトロピン(HCG)
  • 15. インスリン
  • 16. NSE
  • 17. 潜血
  • 18. PAPスメア/HPV
  • 19. 前立腺酸性フォスファターゼ(PAP)
  • 20. 前立腺特異抗原(PSA)
  • 21. 扁平上皮癌関連抗原(SCC)
  • 22. T・Bリンパ球
  • 23. TdT
  • 24. サイログロブリン
  • 25. 組織ポリペプチド抗原(TPA)
  • 26. 生化学腫瘍マーカー
  • 27. 腫瘍遺伝子
  • 28. ポリペプチド増殖因子
  • 29. 異所性ホルモン
  • 30. コロニー刺激因子
  • 31. リンフォカイン
  • 32. 免疫組織化学染色
  • 33. 新興の腫瘍マーカー

付録

図表

目次
Product Code: VPCA8543

The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.

Contains: 260 pages and 30 tables.

Table of Contents

  • 1. Introduction
  • 2. Tumor Marker Classification
  • 3. ACTH
  • 4. Alpha-Fetoprotein (AFP)
  • 5. Beta-2 Microglobulin
  • 6. CA 15-3/27.29
  • 7. CA 19-9
  • 8. CA-125
  • 9. Calcitonin
  • 10. Carcinoembrionic Antigen (CEA)
  • 11. Estrogen and Progesterone Receptors
  • 12. Ferritin
  • 13. Gastrin
  • 14. Human Chorionic Gonadotropin (HCG)
  • 15. Insulin
  • 16. NSE
  • 17. Occult Blood
  • 18. PAP Smear/HPV
  • 19. Prostatic Acid Phosphatase (PAP)
  • 20. Prostate-Specific Antigen (PSA)
  • 21. Squamous Cell Carcinoma Antigen (SCC)
  • 22. T and B Lymphocytes
  • 23. TdT
  • 24. Thyroglobulin
  • 25. Tissue Polypeptide Antigen (TPA)
  • 26. Biochemical Tumor Markers
    • ADA
    • B-Protein
    • PNP
    • 5'-Nucleotidase
  • 27. Oncogenes
    • Abl/abl-bcr
    • AIB1
    • BCL-2
    • BRCA1
    • CD44
    • C-fos
    • C-myb
    • C-myc
    • CYP-17
    • Erb-B
    • HPC1
    • N-myc
    • P40
    • P51
    • P53
    • PIK3CA
    • PTI-1
      • Ras
      • Reg
      • Sis
      • Src
  • 28. Polypeptide Growth Factors
    • Basic Fibroblast Growth Factor
    • Beta-TGF
    • Cachectin (TNT)
    • Calmodulin
    • ECFR
    • Nerve Growth Factor (NGF)
    • Epidermal Growth Factor (EGF)
    • Ornithine Decarboxylase
    • Transferrin
    • Transforming Growth Factor-Alpha
  • 29. Ectopic Hormones
  • 30. Colony Stimulating Factors
  • 31. Lymphokines
    • Alpha-Interferon
    • B Cell Growth Factors
    • B Cell Growth Factor (BCGF)
    • Gamma-Interferon
    • Interleukin-1 (IL-1)
    • Macrophage Activating Factor
  • 32. Immunohistochemical Stains
  • 33. Emerging Tumor Markers
    • N-Acetylglucosamine
    • Actin
    • Alpha-Actin
      • Antineuronal Antibodies
      • 7B2
      • B72.3
      • Bax
      • BCD-F9
      • BLCA-4
      • Blood Group Antigens A,B,H
      • CA 50
      • CA 72-4/TAG-72
      • CA 195
      • CA-242
      • CA-549
      • CAM 26
      • CAR-3
      • Cathepsin-D
      • Chromogranin A and B
      • Cluster 1 Antigen
      • Cluster-5/5A Antigen
      • CTA
      • CU18
      • DR-70
      • DU-PAN-2
      • Endometrial Bleeding Associated Factor
      • Endostatin
      • Epithelial Membrane Antigen
      • Feulgen Hydrolysis
      • Fibronectin
      • FSH
      • (1->3)-L-fucosyltransferase
      • Gastrin-Releasing Peptide (GRP)
      • GDCFP-15
      • Glucagon
      • Glycoamines
      • H23
      • Her-2
      • Human Carcinoma Antigen
      • HPA
      • HSP27
      • Intermediate Filaments
      • Cytokeratins/CK18/Cyfra 21-1
      • Desmin
      • Gliofibrillary Acid Protein
      • Neurofilaments
      • Vimentin
      • KA 93
      • Kinases
      • KP16D3
      • LAI
      • Leukocyte Common Antigen
      • Lewis Antigens
      • Lysophosphatidic Acid (LPA)
      • Ma 695/Ma 552
      • MABDF3
      • MAG
      • ME1
      • Minactivin
      • MN/CA9
      • MSA
      • Mucin Cancer Antigen (MCA)
      • Multiple Tumor Suppressor 1
      • Myosin
      • NEA-130
      • NMP22
      • OA-519
      • Opiod Peptides
      • P-glycoprotein
      • Pancreatic Oncofetal Antigen (POA)
      • Placental Lactogen
      • PR92
      • Proliferative Index, Ki-67
      • Px
      • RB Inactivation/Deletion
      • Ret
      • SCCL 175
      • Selectin
      • Sialic Acid
      • Sialyl SSEA-1/SLX
      • SN10
      • Somatostatin
      • TA-90
      • TABA
      • Tachykinin
      • TAG 12
      • TPS
      • Troponin
      • Tubulin
      • VCAM
      • VEGF
      • Villen

Appendixes

  • Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Back to Top